by The Sharp Edge, Corey’s Digs:
Agencies receiving billions of taxpayer dollars have funded research that led to the Covid bioweapon and mRNA Covid injections which have proven to be more dangerous than the virus itself. These agencies have continued to support gain-of-function research and are fast-tracking mRNA technology for other vaccines and medicines including a “universal flu vaccine.”
TRUTH LIVES on at https://sgtreport.tv/
Congress has authorized a boost in funding through the Omnibus bill and the National Defense Authorization Act of 2023 (NDAA) for the very entities responsible for the Covid catastrophe which has plagued the world. The purpose of this report is to outline the funding of agencies that contribute to the biomedical control grid condensed from 6,000 pages of legislation rushed through Congress at the end of 2022.
Through this legislation, agencies and organizations outlined in this report are tasked with preparing for the next pandemic, developing and stockpiling more mRNA injections, scaling up surveillance tools, research and development of biotechnology, and maintaining U.S. chemical and biological defense programs.
In short, the 2023 Omnibus and NDAA will expand funding of the biomedical control grid using billions of taxpayer dollars.
Background & Context
Agencies Involved in Gain-of-Function Research & the Origins of Covid
- Mountains of evidence now confirm that Fauci’s NIH/NIAID funded dangerous gain-of-function research through EcoHealth Alliance and the Wuhan Institute of Virology leading up to the release of the Covid bioweapon. Furthermore, there is overwhelming evidence, including Fauci’s own emails, that shows attempts by U.S. government agencies as well as the World Health Organization (WHO) to cover it up.
- The Department of Defense (DOD), Health and Human Services (HHS), State Department (USAID,) National Science Foundation (NSF), and others contributed over 120 million dollars to EcoHealth Alliance for years continuing through 2020. About one third of those contributions came directly from the Pentagon, the majority of which came from the Defense Threat Reduction Agency (DTRA), a department of the DOD that focuses on countering and deterring “weapons of mass destruction.”
- Since the release of the Covid bioweapon, U.S. government agencies and organizations including NIH, USAID and NSF have continued to fund and support EcoHealth Alliance using millions of taxpayer dollars. Despite the overwhelming evidence that U.S. agencies and organizations helped to create the Covid bioweapon, in July 2021 the Defense Department’s DTRA awarded EcoHealth a $368,000 contract through September 2024 to conduct scientific research on “combating weapons of mass destruction” and “predicting biothreat impacts.”
- In August 2022 the NSF awarded EcoHealth Alliance and Boston University a 1 million dollar grant to “predict and prevent future pandemics.” Following the partnership between EcoHealth Alliance and Boston University to “predict and prevent future pandemics,” in October 2022 Boston University published more gain-of-function research that created a deadlier Covid virus with an 80% kill rate in mice that were tested. The publication acknowledged NIH and NIAID for their contributions to this research.
Developing & Deploying mRNA Injections More Dangerous Than Covid
- In December 2019 (prior to public knowledge of the release of the Covid bioweapon) a confidential agreement signed by Ralph Baric, a key scientist connected to the origins of Covid, reveals that NIAID and Moderna agreed to transfer research specifically related to “mRNA coronavirus vaccine candidates developed and jointly-owned by NIAID and Moderna.” Based on the confidential agreements, collaboration between NIAID and Moderna on the creation of mRNA-based vaccines dates back to 2015. Furthermore, a study found genetic sequences in the Covid spike protein match genetic sequences patented by Moderna in 2016, which researchers concluded that there is only a one-in-three-trillion chance could occur naturally.
- Under a court-ordered disclosure due to a FOIA request, the FDA released a cache of 80,000 pages of Pfizer documents pertaining to approval of the Covid mRNA injection for Emergency Use Authorization. The documents reveal that Pfizer became aware of deaths and adverse events during clinical trials of the Covid jab but classified almost all adverse events, including serious ones, as “not related,” to the shots. Despite serious adverse events, the dangerous mRNA injections were approved, and even mandated for the masses.
- The latest statistics from the U.S. Vaccine Adverse Event Reporting System (VAERS), the DOD Defense Medical Epidemiology Database (DMED), excess mortality data, as well as published studies and reports have shown catastrophic increases in deaths, disabilities, illnesses, infertility, and miscarriages due to the Covid mRNA jab, confirming that the mRNA injection is much worse than the Covid bioweapon itself.
- Despite the known catastrophic adverse events related to the Covid injection, government agencies are fast-tracking the deployment of mRNA technology for other vaccines and medicines. At least 200 clinical trials are listed in ClinicalTrials.gov for mRNA-based vaccines or medicines and 50 clinical trials are currently enrolling for new mRNA-based vaccines, according to Dr. Malone. NIH-funded research is leading to the creation of a “universal flu vaccine” using mRNA technology. Both Moderna and Pfizer are in phase 3 clinical trials of their mRNA flu injections.
Expanding the Biomedical Control Grid Through Biotechnology, Digital Vaccine Passports & Perpetual Global Health Emergencies
- In March 2022, the Advanced Research Projects Agency for Health (ARPA-H) was created to conduct “high risk, high reward” research for the purposes of “developing mRNA vaccines to prevent most cancers” among several other objectives.
- A September 2022 Biden Executive Order calls for a “whole-of-government approach to advance biotechnology and biomanufacturing,” stating, “We need to develop genetic engineering technologies and techniques to be able to write circuitry for cells and predictably program biology in the same way in which we write software and program computers; unlock the power of biological data, including through computing tools and artificial intelligence; and advance the science of scale‑up production while reducing the obstacles for commercialization so that innovative technologies and products can reach markets faster.”
- In October 2022 Johns Hopkins hosted a Catastrophic Contagion tabletop exercise in partnership with the WHO and the Bill & Melinda Gates Foundation concerning a pandemic in 2025 with a “higher fatality rate than COVID-19 and disproportionately affecting children and young people.” Johns Hopkins also hosted the now infamous Event 201 tabletop exercise in partnership with the World Economic Forum (WEF) and Gates Foundation in October 2019 which predicted the Coronavirus pandemic.
- In November 2022 Biden signed the G20 Declaration, committing to “global health governance” by the World Health Organization (WHO) under “a legally binding instrument” with the intention of handing over national sovereignty to the WHO. The declaration also supports collaboration on “global digital health networks” in response to future pandemics that will “build on the success of the existing standards and digital COVID-19 certificates.”
If history is any indicator, the same entities responsible for Covid atrocities will continue their nefarious behavior with additional funding through the 2023 budget, which is outlined below.
Omnibus Bill Boosts Biomedical Control Grid Agencies
Total funding from the 2023 Omnibus bill reaches $1.7 trillion, a $134 billion increase over the 2022 budget.
- ARPA-H receives $1.5 billion, an increase of $500 million
- Assistant Secretary for Preparedness and Response receives $3.3 billion, an increase of $560 million
- BARDA receives $950 million, an increase of $205 million
- CDC receives $9.2 billion, an increase of $760 million
- FDA receives $3.5 billion, an increase of $226 million
- Global Health Programs & Pandemic Prevention receive $10.6 billion divided among the State Department with $6.4 billion and USAID with $4.2 billion
- HHS receives $120.7 billion, an increase of $9.9 billion
- NIH receives $47.5 billion, an increase of $2.5 billion
- NSF receives $9.9 billion, an increase of $1.036 billion (largest dollar increase in NSF history)
Agencies who are part of the biomedical control grid funded through the Omnibus bill are mandated to prepare for the next pandemic, funnel more taxpayer dollars towards the development and stockpiling of mRNA injections, as well as expand surveillance tools. Sections and page numbers referenced below can be found in the Omnibus bill here.
Strategic Planning for the Next Pandemic
- In Section 2001, there is no language to offer real reform of the CDC following their reckless behavior since the Covid outbreak. Instead, as part of the PREVENT Pandemics Act tucked into the Omnibus the President’s nomination for Director of the CDC must be confirmed by the Senate by January 2025 and the agency must come up with an agency-wide strategic plan to prepare for the next pandemic, known as the “CDC Strategic Plan.”
- In Section 2103, the section entitled “Public Health and Medical Preparedness and Response Coordination” outlines the duties of the Administration for Strategic Preparedness and Response (ASPR) to coordinate with all other federal agencies as well as state and local governments in response to any future so-called “public health emergencies.” Full-scale exercises on the national and state levels are required at least every 4 years.
- In Section 2104, Congress established a new pandemic czar under the President in the “Office of Pandemic Preparedness and Response Policy.” The President appoints the Director of this office. The primary function of this new pandemic czar is to provide advice to the President on preparedness and response to pandemics and any other biological threat to national security. The new pandemic czar is also tasked with coordinating all federal activities and providing strategic direction to all directors of applicable federal agencies to respond to a pandemic or biological threat to “facilitate a whole-of-Government response to such threats.” Furthermore, the new pandemic czar is mandated to assess and advise on “international cooperation” in response to such threats, as well as coordinate activities using emerging technologies “which may advance the biosecurity and preparedness and response goals of the Federal Government.”
- In Section 2235, “to address zoonotic diseases and advance public health preparedness,” HHS, CDC and other agencies are tasked with developing a mechanism for coordination across the entire federal government on a “One Health Framework.”
- In Section 7058, entitled “Global Health Activities,” funds appropriated under “Global Health Programs” allocated to the State Department and USAID are to be used for the purpose of accelerating the capacity of other countries to prevent, detect and respond to outbreaks. Additional funds in the amount of $200 million may be transferred from other programs if the Secretary of State determines that an outbreak is in our national interest to respond to a “Public Health Emergency of International Concern.” Funding of “Global Health Programs” to address pandemics is specifically restricted from use at the Wuhan Institute of Virology, but no mention under this section of limitations on funds used at other institutes like it.
Biomedical R&D, Stockpiling mRNA Injections
- On page 1009, the “National Human Genome Research Institute,” receives $663,200,000 “with respect to human genome research.”
- Also on page 1009, the “National Institute of Biomedical Imaging and Bioengineering” receives $440,627,000.
- On page 1044, the “Public Health and Social Services Emergency Fund,” allocates $1.647 billion to counter “potential biological, nuclear, radiological, chemical, and cybersecurity threats to civilian populations, and for other public health emergencies.” Through September 2024, $950 million remains available to BARDA for “advanced research and development” of countermeasures or “qualified pandemic or epidemic products.” From these funds, $75 million is made available for the “development, production and distribution of vaccines, therapeutics and other medical countermeasures” through September 2024. Products purchased under this section must be deposited in the Strategic National Stockpile.
- On page 1046, additional funds are provided in the amount of $335 million to respond to a flu pandemic. Of those funds, $300 million is available for the development and purchase of flu vaccines, antivirals, medical supplies, diagnostics and “other surveillance tools.” There is no mention of the “Flu Vaccine Act,” in this section but Senator Markey boasted that $270 million in funding was secured through the Omnibus under the “Flu Vaccine Act,” for the research and development of a “universal flu vaccine,” which is essentially a flu mRNA injection.
- Also on page 1046, Congress authorizes funding for the new ARPA-H in the amount of $1.5 billion to be used towards grants and contracts for advanced research projects related to health through September 2025. Furthermore, in Section 2331, the functions of ARPA-H are outlined, including language intended to allow ARPA-H independence from other agencies, creating an agency with little transparency or accountability while promoting “high-risk, high-reward” research to “foster the development of novel, breakthrough, and broadly applicable capabilities and technologies to accelerate transformative innovation in biomedical science and medicine in a manner that cannot be readily accomplished through traditional Federal biomedical research and development programs or commercial activity.”
- On page 1307, under the section entitled “Global Health Programs,” $4.165 billion is allocated to USAID in part for immunization programs as well as preparing for and responding to emerging global health threats in other countries. Funds appropriated under this section may be made available for contributions to Bill Gates’ GAVI Vaccine Alliance “and to a multilateral vaccine development partnership to support epidemic preparedness.”
- In Section 2301, entitled “Accelerating Research and Countermeasure Discovery” and “Fostering Research and Development and Improving Coordination,” a new section of the “Public Health Service Act” has been inserted which is entitled, “Research Centers for Pathogens of Pandemic Concern.” In this newly inserted section, a collaboration between institutes, centers, and divisions of NIH, ASPR, and BARDA is mandated for the purposes of “a multidisciplinary research program to advance the discovery and preclinical development of medical products for priority virus families and other viral pathogens with a significant potential to cause a pandemic.” The funds appropriated in this section are to be used towards grants, contracts and agreements for the research and development of new medical technologies including “platform technologies.” (The term “platform technologies” can be used to describe mRNA technology without actually stating “mRNA” in the Omnibus bill. For perspective, a keyword search of the Omnibus produces zero results for “mRNA” whereas “platform tech” appears throughout the Omnibus bill 40 times.)
- In Section 2311, entitled “Improving Biosafety and Biosecurity,” and “Improving Control and Oversight of Select Biological Agents and Toxins,” new procedures for reporting and mitigating threats “in the event of the release, loss, or theft of an agent or toxin,” from HHS or federal laboratories are outlined.
- In Section 2312, entitled “Strategy for Federal High-Containment Laboratories,” the Director of the Office of Science and Technology Policy is tasked with establishing a strategy for management, maintenance, and oversight of federally owned Biosafety Level 3 and 4 labs. Included in the strategy, the director must outline a summary of plans for determining if capacity should be expanded and a “description of how the Federal Government will address rapid changes in the need for such capacity within each relevant Federal department or agency during a public health emergency.”
- In Section 2313, a “National Science Advisory Board for Biosecurity” is mandated to provide guidance to federal agencies related to biosafety and biosecurity oversight which includes oversight of “federally-conducted or federally-supported dual use biomedical research.” (The term “dual use” refers to pathogens that can be used for both scientific research as well as bioweapons.)
- In Section 2315, entitled “Federally-Funded Research with Enhanced Pathogens of Pandemic Potential,” the Director of the Office of Science and Technology Policy is expected to review, update, and provide oversight for policies related to the federal funding involved in “the creation, transfer or use of enhanced pathogens of pandemic potential.”
- Also in Section 2315, entitled “Limitations on Countries of Concern Conducting Certain Research,” HHS is restricted from funding research “conducted by a foreign entity at a facility located in a country of concern… involving pathogens of pandemic potential or biological agents or toxins.”
- In Section 2321, entitled “Preventing Undue Foreign Influence in Biomedical Research,” and “Foreign Talent Recruitment Programs,” NIH personnel who are engaged in intramural research are prohibited from participating in foreign talent recruitment programs, though exemptions may be approved by NIH. As for extramural research, participation in foreign talent recruitment programs must be disclosed prior to receiving biomedical research funding through HHS.
